Mandate

Vinge advises Swedish Match in the acquisition of Gotlandssnus

July 31, 2018 M&A

Founded in 2002, Gotlandssnus develops, produces, and sells both snus and nicotine-free products, with sales in Sweden, the US, Asia, and parts of Europe.

The company sells popular brands such as Jakobsson’s snus and Qvitt (nicotine and tobacco free pouches). Gotlandssnus produces approximately 4 million cans per year. The production facility and head office are located in Romakloster, Gotland. The current managing director and founder Henrik Jakobsson will remain as the managing director of Gotlandssnus and also as a minority shareholder of the company.
 
Vinge’s team consisted of partner Jonas Johansson and associate Karl Klackenberg.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024